Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells
Authors:
- Pei-Chi HouPHPei-Chi Hou
- Kuan-Der LeeKLKuan-Der Lee
- Pei-Yi ChuPCPei-Yi Chu
- Kun-Tu YehKYKun-Tu Yeh
- Victor X. JinVJVictor X. Jin
- Min-Jen TsengMTMin-Jen Tseng
- Shaw-Jenq TsaiSTShaw-Jenq Tsai
- Yu-Sun ChangYCYu-Sun Chang
- Chi-Sheng WuCWChi-Sheng Wu
- H. Sunny SunHSH. Sunny Sun
- Kuen-Daw TsaiKTKuen-Daw Tsai
- 30 June 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (13) , 4653-4663
Abstract
Although DNA hypermethylation within promoter CpG islands is highly correlated with tumorigenesis, it has not been established whether DNA hypermethylation within a specific tumor suppressor gene (TSG) is sufficient to fully transform a somatic stem cell. In this study, we addressed this question using a novel targeted DNA methylation technique to methylate the promoters of HIC1 and RassF1A, two well-established TSGs, along with a two-component reporter system to visualize successful targeting of human bone marrow–derived mesenchymal stem cells (MSC) as a model cell system. MSCs harboring targeted promoter methylations of HIC1/RassF1A displayed several features of cancer stem/initiating cells including loss of anchorage dependence, increased colony formation capability, drug resistance, and pluripotency. Notably, inoculation of immunodeficient mice with low numbers of targeted MSC resulted in tumor formation, and subsequent serial xenotransplantation and immunohistochemistry confirmed the presence of stem cell markers and MSC lineage in tumor xenografts. Consistent with the expected mechanism of TSG hypermethylation, treatment of the targeted MSC with a DNA methyltransferase inhibitor reversed their tumorigenic phenotype. To our knowledge, this is the first direct demonstration that aberrant TSG hypermethylation is sufficient to transform a somatic stem cell into a fully malignant cell with cancer stem/initiating properties. Cancer Res; 71(13); 4653–63. ©2011 AACR.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Epigenetic Silencing of the RASSF1A Tumor Suppressor Gene through HOXB3-Mediated Induction of DNMT3B ExpressionMolecular Cell, 2009
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumorsThe International Journal of Biochemistry & Cell Biology, 2009
- Microenvironmental regulation of cancer developmentCurrent Opinion in Genetics & Development, 2008
- The Salvador-Warts-Hippo Pathway Is Required for Epithelial Proliferation and Axis Specification in DrosophilaCurrent Biology, 2007
- Phenotypic plasticity and the epigenetics of human diseaseNature, 2007
- The Epigenomics of CancerCell, 2007
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingNature Genetics, 2007
- Adult human mesenchymal stem cell as a target for neoplastic transformationOncogene, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004